Christine Blank
SPAARx protests rules on refill reminders, marketing
The Specialty Pharmacy Association of America is concerned about the language involving refill reminders and marketing in the U.S. Department of Health and Human Services’ newly released revisions to HIPAA concerning the HITECH Act.
NABP study says rogue websites are rampant
Nearly all prescription drug websites geared toward Americans are operating out of compliance with U.S. pharmacy laws, according to a study by the National Association of Boards of Pharmacy.
States want Google to remove ads from websites selling illegal Rxs
The top law enforcement officials in two states have asked Google to remove video ads from YouTube that promote rogue websites for medications, including those featuring “no prescription required” products.
Study finds Rx abuse among teens is a big problem
More than a third of young people believe prescription stimulant abuse is a big problem among their peers, according to a new survey.
New oral anticoagulants increase risk for GI bleeding
New oral anticoagulants increase risk for GI bleeding
Patients taking the new generation of oral anticoagulants are associated with a significantly higher risk of gastrointestinal bleeding, according to a study published in the July 2013 issue of Gastroenterology.
Medtronic recalls MiniMed insulin infusion sets
FDA sent out a MedWatch warning, on July 12, 2013, after Medtronic recalled its MiniMed Paradigm insulin infusion sets.
Telmisartan and valsartan present lower risk of heart attack and strokes in diabetes patients
Telmisartan and valsartan, used to reduce blood pressure in people with diabetes, are associated with a lower risk of hospitalization for heart attack, stroke, or heart failure, according to a study published on the Canadian Medical Association Journal.
Study: EHRs don’t reduce inpatient costs
The use of electronic health records saved more than 3% in ambulatory health costs but did not reduce overall inpatient costs, according to a study published in the July 16, 2013 issue of Annals of Internal Medicine.
Dosage errors common with Humulin R U-500 insulin
The Institute for Safe Medication Practices (ISMP) continues to receive reports of dose measurement confusion with Humulin R U-500 concentrated insulin injection, according to a recent safety alert from the agency.
Statins offer 30% lower risk of COPD exacerbation
Statins offer 30% lower risk of COPD exacerbation
A new retrospective case-control study among patients with chronic obstructive pulmonary disease found a 30% decreased risk of COPD exacerbation with any statin use.

Poll